PO.PS01.08 · 人群科学
智利早发胃癌患者的种系致病性变异
Germinal pathogenic variants in Chilean early-onset gastric cancer patients
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
目的:本研究旨在识别和描述在159例智利早发胃癌(EOGC)患者中发现的致病性/可能致病性(P/LP)种系变异。
引言:早发胃癌(EOGC),即在45或50岁之前诊断的胃癌,越来越被认识为一种独特的临床实体。家族性胃癌在家庭内聚集出现,且常为早发,与特定的遗传综合征相关。遗传性胃癌(HGC)约占所有胃癌病例的10%,其中CDH1基因突变是HGC中最常见的观察结果。我们团队此前的一份报告描述了一个携带致病性CDH1变异的智利遗传性弥漫型胃癌(HDGC)家系,提示该人群中致病性变异的频率较低。
方法:对124例患者进行了基因panel分析,对35例患者使用Agilent SureSelect Human All Exome V7试剂盒进行了全外显子组测序(WES)。使用Dragen v3.8进行比对和变异检出,并使用Illumina Nirvana和Annovar对变异进行注释。使用PCR和Sanger测序对先证者及其亲属进行基因分型。
结果:在11例患者中,跨5个基因识别出9个P/LP种系变异。在CDH1基因中未发现P/LP致病变异,与先前发现一致。在一名患者中发现CTNNA1基因的一个P/LP变异(c.531T>G,p.Tyr177Ter)。此外,在一个大的HDGC家系中发现了一个高CADD评分的意义未明变异(VUS)(c.293G>A,p.Arg98Gln)。识别出两个BRCA2 P/LP变异:c.4740_4741dupTG(p.Glu1581fs)见于两名无亲缘关系的患者,c.5439delT(p.Leu1813_Val1814insTer)见于一名患者,这两个变异此前均在智利遗传性乳腺癌患者中被描述过。识别出三个ATM P/LP变异,包括在一个有三名受累个体的家系中的c.3381_3384del(p.Gln1128fs),以及在其他无亲缘关系患者中的c.3894dup(p.Ala1299fs)和c.8122G>A(p.Asp2708Asn)。在三个独立病例中发现一个RUNX1变异(c.1270T>G,p.Ser424Ala),在一个有多例胃癌病例的家系中识别出一个POT1变异(c.1087C>T,p.Arg363Ter)。
结论:这些家系表现出不完全外显性和多器官癌症。这是遗传性胃癌中RUNX1和POT1基因P/LP变异的首次报告。RUNX1与遗传性髓系恶性肿瘤相关,POT1与遗传性结直肠癌相关。本研究为智利人群早发胃癌的遗传学基础提供了新见解,突显了在家族性胃癌综合征中进一步研究这些变异的必要性。
资助:Beca Chile Postdoctorado 74190063、CONICYT-FONDAP 15130011/ANID-FONDAP apoyo 1523A0008、FONDECYT 1231773、NIH R01CA223978、R21CA199631、U54CA233306和P30CA093373。
查看英文原文 English abstract
Aim: This study aims to identify and describe the pathogenic/likely pathogenic (P/LP) germline variants found in 159 Chilean patients with early-onset gastric cancer (EOGC).
Introduction: Early-onset gastric cancer (EOGC), diagnosed before the age of 45 or 50, is increasingly recognized as a distinct clinical entity. Familial gastric cancer, which clusters within families often with early onset, is associated with specific genetic syndromes. Hereditary gastric cancer (HGC) accounts for about 10% of all gastric cancer cases, with mutations in the CDH1 gene being the most frequently observed in HGC. A previous report from our group described a Chilean family with hereditary diffuse gastric cancer (HDGC) harboring a pathogenic CDH1 variant, suggesting a lower frequency of pathogenic variants in this population.
Methods: Gene panel analysis was performed on 124 patients, and whole-exome sequencing (WES) was conducted on 35 patients using the Agilent SureSelect Human All Exome V7 kit. Alignment and variant calling were performed using Dragen v3.8, and variants were annotated with Illumina Nirvana and Annovar. Genotyping of index patients and their relatives was done using PCR and Sanger sequencing.
Results: Nine P/LP germline variants were identified across five genes in 11 patients. No P/LP pathogenic variants were found in the CDH1 gene, consistent with prior findings. A P/LP variant in the CTNNA1 gene (c.531T>G, p.Tyr177Ter) was found in one patient. Additionally, a high CAAD score variant of uncertain significance (VUS) (c.293G>A, p.Arg98Gln) was found in a large HDGC family. Two BRCA2 P/LP variants were identified: c.4740_4741dupTG (p.Glu1581fs) in two unrelated patients and c.5439delT (p.Leu1813_Val1814insTer) in one patient, both variants having been previously described in Chilean hereditary breast cancer patients. Three ATM P/LP variants were identified, including c.3381_3384del (p.Gln1128fs) in a family with three affected individuals, and c.3894dup (p.Ala1299fs) and c.8122G>A (p.Asp2708Asn) in other unrelated patients. A RUNX1 variant (c.1270T>G, p.Ser424Ala) was found in three independent cases, and a POT1 variant (c.1087C>T, p.Arg363Ter) was identified in a family with multiple gastric cancer cases.
Conclusion: These families exhibited incomplete penetrance and multi-organ cancers. This is the first report of P/LP variants in the RUNX1 and POT1 genes in hereditary gastric cancer. RUNX1 is associated with hereditary myeloid malignancies, and POT1 with hereditary colorectal cancer. This study provides new insights into the genetic basis of early-onset gastric cancer in the Chilean population, highlighting the need for further investigation of these variants in familial gastric cancer syndromes.
Funding: Beca Chile Postdoctorado 74190063, CONICYT-FONDAP 15130011 /ANID-FONDAP apoyo 1523A0008, FONDECYT 1231773, NIH R01CA223978, R21CA199631, U54CA233306, and P30CA093373.
利益披露 Disclosure
G. Molina Fuentes, None..
E. Norero Muñoz, None..
A. P. Estrada-Florez, None..
P. Lott, None..
G. Lay-Son, None..
P. González Canales, None..
C. Parra, None..
O. Torres, None..
J. Martínez, None..
C. Adelsdorfer, None..
G. Llewelyn, None..
A. Corvalán, None..
L. G. Carvajal-Carmona, None.